IP Library Patent Application 15302715
Patent Application
App. No. 15/302,715

GENDER SPECIFIC SYNTHETIC NUTRITIONAL COMPOSITIONS AND NUTRITIONAL SYSTEMS COMPRISING THEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/302,715
Abstract

Gender specific synthetic nutritional compositions for infants up to 1 month of age wherein, the caseins content is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.

Claims (16)

1 . A gender specific synthetic nutritional composition for an infant up to 1 month of age, wherein, the caseins concentration of the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

2 . A gender specific synthetic nutritional composition according to claim 1 wherein, the caseins concentration of the composition is adapted to a male infant and is 3598.2 mg to 10512.2 mg per L.

3 . A gender specific synthetic nutritional composition according to claim 1 wherein, the caseins concentration of the composition is adapted to a female infant and is 1118.3 mg to 9509.9 mg per L.

4 . A composition according to claim 1 wherein, the gender specific synthetic nutritional composition is selected from the group consisting of: infant formula, and a composition for infants that is intended to be added to or diluted with human milk.

5 . A method of preparing a composition comprising: measuring out an appropriate amount of a gender neutral synthetic nutritional composition and mixing it with an additive and/or diluent to produce a composition comprising a gender specific synthetic nutritional composition for an infant up to 1 month of age, wherein, the caseins concentration of the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

6 . A nutritional system comprising a gender specific synthetic nutritional composition for an infant up to 1 month of age, wherein, the caseins concentration of the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

7 . A nutritional system according to claim 6 comprising a gender specific synthetic nutritional composition for a male infant wherein the caseins concentration is 3598.2 mg to 10512.2 mg per L and, a gender specific nutritional compositions for a female infant wherein the caseins concentration is 1118.3 mg to 9509.9 mg per L.

8 . A nutritional system according to claim 7 wherein the caseins concentration in the male gender specific synthetic nutritional composition is higher than that of the female gender specific synthetic nutritional composition.

9 . A nutritional system according to claim 6 further comprising gender specific synthetic nutritional compositions for infants of more than 1 month of age wherein, the caseins concentration does not differ by gender for infants of the same age.

10 . A nutritional system according to claim 6 further comprising gender neutral synthetic nutritional compositions for infants of more than 1 month of age.

11 . (canceled)

12 . A method for use to treat, protect or mitigate sub optimal growth and development of an infant comprising administering a gender specific synthetic nutritional composition to an infant up to 1 month of age, wherein, the caseins concentration of the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

13 - 14 . (canceled)

15 . A kit for providing an optimized amount of caseins to an infant, the kit comprising;

a gender neutral synthetic nutritional composition; and

a label indicating dosage requirements for an infant so as to arrive at a gender specific nutritional composition, the gender specific synthetic nutritional composition for an infant up to 1 month of age, wherein, the caseins concentration of the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2017
From: AFFOLTER, MICHAEL; THAKKAR, SAGAR; DE CASTRO, CARLOS ANTONIO
To: NESTEC S.A.
Reel/Frame 043410/0876 →